HLN (Haleon) Total Equity: $22,067 Mil (As of Dec. 2025)


HLN Haleon PLC HLN
70 GF Score
Price $9.82
GF Value $9.79
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Haleon Total Equity?

Haleon HLN +4.47% 70 Total Equity is $22,067 Mil as of Dec. 2025. GuruFocus rates HLN with a GF Score™ of 70/100 and a GF Value™ of $9.79 (Fairly Valued). The stock has 3 warning signs investors should review.

Haleon's total equity for the quarter that ended in Dec. 2025 was $22,067 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Haleon Total Equity Historical Data

* Premium members only.

The historical data trend for Haleon's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Total Equity Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 35,212.77 20,045.07 21,175.95 20,510.75 22,066.93

Haleon Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21,175.95 21,255.73 20,510.75 21,706.92 22,066.93
HLN
70GF Score
Haleon PLC HLN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleon Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Haleon's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=43681.392-21614.458
=22,067

Haleon's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=43681.392-21614.458
=22,067

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $22,067 Mil mean?
Haleon (HLN) has a Total Equity of $22,067 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Haleon and its competitors.
Is Haleon's Total Equity too high?
Haleon's current Total Equity is $22,067 Mil. Overall, Haleon has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Total Equity compare to ZTS and UTHR?
Haleon's Total Equity of $22,067 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Haleon and its competitors. Haleon's current Total Equity is $22,067 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (HLN) is currently considered Fairly Valued. The stock's GF Value™ is $9.79, compared to a current price of $9.82 — trading 0.3% above its estimated fair value. The current Total Equity is $22,067 Mil. Haleon's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Haleon (HLN), the current Total Equity is $22,067 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleon (HLN) Overvalued in 2026?

Based on GuruFocus' analysis, Haleon stock appears to be overvalued. The current stock price of $9.82 is trading 0.3% above its estimated GF Value™ of $9.79. GuruFocus considers Haleon to be Fairly Valued.

Key valuation signals for HLN:

  • Total Equity: $22,067 Mil
  • GF Value™: $9.79 vs. price of $9.82 (0.3% above fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the HLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleon Business Description

Address The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
70GF Score

Get the complete analysis for HLN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.82
Price
$9.79
GF Value